Delivery Order SPE2DB20D3101-SPE2DB21FK5J8

Award Date 9/15/21
Potential Completion Date 9/16/21
Potential Value $1.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product Spiriva Respimat 1.25 MCG INH 4GM to the Defense Logistics Agency (DLA). The contract, valued at $1,758.81, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $1,786.67 under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,177.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Spiriva Respimat 1.25 MCG INH 4GM, a pharmaceutical product used for respiratory conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of July 19, 2023. The award was made through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalers to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $7,112.62. The contract has a firm fixed price and is set to be completed by April 25, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, valued at $1,102.08. The award was made by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract has a ceiling value of $1,102.08 and is a delivery order under an Indefinite Delivery Contract (IDC) held...
This federal contract award is for the delivery of pharmaceutical products, specifically SPIRIVA RESPIMAT 2.5 MCG INH 4GM, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $1,889.17 and is a Firm Fixed Price Delivery Order with an ultimate completion date of October 24, 2023. The contract was not set aside for any specific program....
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $3,223.51 and is a Firm Fixed Price Delivery Order. It has an ultimate completion date of October 30, 2023. Amerisourcebergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The award, valued at $1,571.89, is for the delivery of Spiriva Respimat 2.5 MCG INH 4GM, a respiratory medication. The contract is a firm fixed-price delivery order with an ultimate completion date of March 23, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Spiriva Respimat 2.5 MCG inhalation medication. The $3,519.87 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 8, 2021 with a completion date of September 9, 2021. The contract does not have any set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 16, 2022 with a ceiling value of $1,459.10. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC,...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB21FK5J8
    Delivery Order

This federal contract award is for the delivery of Spiriva Respimat 1.25 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,541.04, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 15, 2021. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a larger pharmaceutical distribution company. This contract is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Cencora, Inc. to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 1:38 PM